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of malaria-induced acute kidney injury
Marlies E. van Wolfswinkel1,2*, Liese C. Koopmans1, Dennis A. Hesselink3, Ewout J. Hoorn3, Rob Koelewijn2, 
Jaap J. van Hellemond2 and Perry J. J. van Genderen1
Abstract 
Background: Acute kidney injury (AKI) is a frequently encountered complication of imported Plasmodium falciparum 
infection. Markers of structural kidney damage have been found to detect AKI earlier than serum creatinine-based 
prediction models but have not yet been evaluated in imported malaria. This pilot study aims to explore the predic-
tive performance of neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule-1 (KIM-1) for AKI in 
travellers with imported P. falciparum infection.
Methods: Thirty-nine patients with imported falciparum malaria from the Rotterdam Malaria Cohort with available 
serum and urine samples at presentation were included. Ten of these patients met the criteria for severe malaria. The 
predictive performance of NGAL and KIM-1 as markers for AKI was compared with that of serum creatinine.
Results: Six of the 39 patients (15 %) developed AKI. Serum and urine NGAL and urine KIM-1 were all found to have 
large areas under the receiver operating characteristics curves (AUROC) for predicting AKI. Urine NGAL was found to 
have an excellent performance with positive predictive value (PPV) of 1.00 (95 % CI 0.54–1.00), a negative predictive 
value (NPV) of 1.00 (95 % CI 0.89–1.00) and an AUROC of 1.00 (95 % CI 1.00–1.00).
Conclusion: A good diagnostic performance of NGAL and KIM-1 for AKI was found. Particularly, urine NGAL was 
found to have an excellent predictive performance. Larger studies are needed to demonstrate whether these bio-
markers are superior to serum creatinine as predictors for AKI in P. falciparum malaria.
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Background
Malaria-induced acute kidney injury (AKI) is an impor-
tant contributing factor to the high mortality of severe 
malaria [1]. In endemic regions, AKI occurs in up to 40 % 
of adult patients with severe Plasmodium falciparum 
infection and it is associated with high mortality [2–5]. 
Outside endemic countries, AKI is also a frequently 
encountered complication of imported P. falciparum 
infection. In a recent study in travellers with imported 
P. falciparum infection, AKI, defined according to the 
criteria set by the Kidney Disease: Improving Global 
Outcomes (KDIGO) AKI Work Group [6], was seen in 39 
(8 %) of all 485 patients and in 23 (38 %) of the 61 patients 
with severe malaria [7].
Although the KDIGO classification allows for an early 
detection of changes in glomerular filtration rate (GFR), 
the use of serum creatinine-based prediction models for 
AKI has limitations. Substantial rises in serum creatinine 
are only observed 48 to 72 h after the initial injury to the 
kidney, and, because of factors such as enhanced tubular 
creatinine secretion, significant renal injury can occur 
without an important rise of serum creatinine [8]. This 
is illustrated by a recent study in which 12 (31 %) of 39 
patients with malaria-induced AKI had a normal serum 
creatinine at presentation [7]. Because structural kidney 
injury precedes functional injury, a marker of structural 
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kidney damage could theoretically detect AKI much ear-
lier, in a way that has been compared to the role of tro-
ponin in the detection of myocardial injury [9].
A promising marker of structural kidney damage 
in AKI is neutrophil gelatinase-associated lipocalin 
(NGAL), also known as lipocalin 2. This protein was ini-
tially discovered in activated neutrophils and was later 
found to be produced by many tissues, including renal 
tubular epithelial cells. Under physiologic conditions, 
NGAL is present at very low concentrations in the urine 
and plasma [10–12]. Studies in animals showed NGAL 
to be one of the most upregulated genes in the kidney 
very early after AKI. As a consequence of the induction 
of NGAL-expression in the distal nephron and reduced 
proximal tubular re-uptake due to tubular damage, both 
urine and plasma NGAL concentrations rise quickly in 
the event of AKI [10, 11]. The value of NGAL as a predic-
tor of AKI has been established in a large number of stud-
ies, predominantly performed in critically ill patients, 
after cardiac surgery and after kidney transplantation 
[11, 13, 14]. In studies in endemic regions, urine NGAL 
has been shown to rise with increasing severity of AKI in 
severe malaria [2] but was not superior to creatinine in 
predicting in hospital requirement for renal replacement 
therapy (RRT) [15]. However, NGAL has not yet been 
evaluated as a marker for AKI in patients with imported 
malaria.
Another frequently used biomarker for kidney injury is 
kidney injury molecule-1 (KIM-1). KIM-1 is a transmem-
brane protein in tubular kidney cells that is undetectable 
in plasma of patients with undamaged kidneys. In dam-
aged tubular epithelial cells undergoing dedifferentia-
tion and proliferation, KIM-1 is induced and can become 
detectable in plasma and urine [16]. The exact function 
of KIM-1 is unknown and reports have suggested both a 
protective and a damaging function of the molecule [16]. 
Urinary KIM-1 concentrations were found to increase 
much earlier than blood urea nitrogen and plasma cre-
atinine in studies in which proximal tubule injury was 
induced by cadmium or ischemia [8, 17, 18]. Its perfor-
mance as an early marker for AKI has been evaluated 
in several clinical settings, including contrast-induced 
nephropathy [19–21] and sepsis [20], but not during 
malaria.
The aim of this pilot study was to explore the predictive 
performance of NGAL and KIM-1 in AKI in travellers 
with imported P. falciparum infection.
Methods
Patients
The Harbour Hospital is a 161-bed general hospital, 
located in Rotterdam, The Netherlands. It also har-
bours the Institute for Tropical Diseases, which serves 
as a national referral centre. The Rotterdam Malaria 
Cohort consists of all patients diagnosed with malaria 
at the Institute for Tropical Diseases since 1998. Of all 
these patients, anonymized demographic, clinical and 
laboratory data are routinely collected and stored in an 
electronic database. On 1 January, 2015, the Rotter-
dam Malaria Cohort comprised 690 cases of imported 
malaria, of which 491 were caused by P. falciparum.
The present pilot study focussed on the diagnos-
tic accuracy of serum NGAL (sNGAL), urine NGAL 
(uNGAL) and urine KIM-1 (uKIM-1) concentrations 
as predictive biomarkers for AKI. Thirty-nine patients 
with imported falciparum malaria from the Rotterdam 
Malaria Cohort with available serum and urine samples 
at their initial presentation were included. Ten patients 
with imported P. falciparum met the criteria for severe 
malaria. The findings were compared with the perfor-
mance of serum creatinine as a marker for AKI in falci-
parum malaria.
Laboratory investigations
All laboratory parameters were measured on admission 
with routine procedures, as described before [22]. The 
standard procedure to diagnose malaria comprised a 
quantitative buffy coat (QBC) analysis, a rapid diagnostic 
test (RDT) for malaria antigens (Binax NOW® Malaria 
Test Binax, Inc, Maine, USA), and thick and thin blood 
smears using freshly collected blood specimens from 
finger pricks. The RDT and the QBC analysis were per-
formed according to the manufacturer’s instructions [23, 
24]. QBC capillaries were examined independently by 
two technicians by microscopic analysis of two complete 
rows of the region between the bottom of the capillary 
and the polynuclear leukocyte layer using an Olympus 
BX-60 fluorescence microscope equipped with UV-filter, 
50× objective and 12.5× oculars (total magnification 
625×).
Measurements of sNGAL, uNGAL and uKIM-1 were 
done using residual patient material. Samples of serum 
and urine had been collected at initial presentation and 
stored at −80 °C until analysis. sNGAL with a maximum 
storage time of 2 years and 9 months, during which sta-
bility of NGAL and KIM-1 levels can be assumed [25]. 
uNGAL and uKIM-1 were quantitatively determined 
with commercially available sandwich ELISA kits (NGAL 
Quantikine and KIM-1 Quantikine kits from R&D Sys-
tems, Inc, Minneapolis, USA).
Definitions
Acute kidney injury
AKI was defined using the KDIGO criteria, which include 
three stages of progressive renal dysfunction (see Addi-
tional file  1) [6]. Since patients may present with renal 
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dysfunction without a known baseline serum creatinine, 
a classification based on a change of creatinine or esti-
mated GFR (eGFR) from baseline poses a significant limi-
tation. To circumvent this problem, the following method, 
which was previously described as a suitable method by 
the ADQI Group [26], was used: in patients without pre-
viously measured creatinine concentrations, a normal 
premorbid renal function was assumed. A baseline, cre-
atinine concentration was then calculated, using the four-
variable modification of diet in renal disease (MDRD) 
formula with an assumed normal eGFR. These calculated 
baseline values were used to estimate the change of renal 
function during infection (see Additional file 2).
Severe malaria
Patients were considered as having severe falciparum 
malaria if they met the recently updated World Health 
Organization (WHO) criteria for severe malaria on 
admission or during hospitalization (see Additional 
file 3) [27].
Statistical analysis
All data were extracted from the original secured data-
base and reviewed for inconsistencies and missing values. 
For statistical analysis, IBM Statistical Package for the 
Social Sciences (SPSS) version 22 (IBM Inc, Chicago, IL, 
USA) was used. Differences between the groups having 
AKI or no AKI were analysed using the Fisher’s exact test 
or Chi square test for nominal variables. For continues 
variables the Mann–Whitney U test was used. The diag-
nostic performance of sNGAL, uNGAL, the uNGAL/
sNGAL ratio, the ratio between uNGAL and urine cre-
atinine (uNGAL/uCreat) and the ratio between uKIM-1 
and urine creatinine (uKIM-1/uCreat) was reported 
as sensitivity, specificity, positive, and negative predic-
tive value for AKI with their corresponding 95 % confi-
dence intervals (with the use of MedCalc version 15.6). 
For each parameter, a receiver operating characteristics 
(ROC) curve was constructed as a summary statistic and 
the area under the ROC curve (AUROC) and its corre-
sponding 95 % confidence intervals were calculated. The 
AUROC of each of the variables was compared to that of 
reference comparator variable serum creatinine in a pair-
wise comparison using the method of Hanley and McNeil 
[28]. Optimal cut-off points were determined using the 
Youden index. All reported P values are two-tailed. P val-
ues less than 0.05 were considered statistically significant.
Results
Patient characteristics and AKI at presentation and during 
admission
During the study period, 50 patients with P. falciparum 
malaria were included in the Rotterdam Malaria Cohort. 
Ten of these patients met the criteria for severe malaria 
and seven had AKI. Of 39 of these patients, including the 
ten patients with severe malaria and six of the patients 
with AKI, residual urine and serum samples were availa-
ble for analysis. The general characteristics on admission 
of these 39 patients are shown in Table  1. Six patients 
(15 %) developed AKI, defined as KDIGO stage 1, 2 or 3, 
in the course of their infection. In four of these patients 
(67  %) AKI was already identified on admission; one 
patient was classified in KDIGO stage 1, two in stage 2 
and one in stage 3. Two of these patients later progressed 
to a more advanced KDIGO stage. Two patients did not 
meet the KDIGO criteria at presentation but progressed 
during admission to KDIGO stage 3 (see Table 2).
The non-AKI group contained more men than de 
AKI group but other demographic findings did not dif-
fer significantly. Pulse rate, parasite load and serum con-
centrations of creatinine, urea, lactate, sNGAL, uNGAL 
and uKIM-1 were significantly higher in the AKI group. 
Serum sodium and potassium concentrations were sig-
nificantly lower in the AKI group. The ratios uNGAL/
sNGAL and of uNGAL/uCreat were significantly higher 
in the AKI patients. Intensive care unit admission was 
significantly more common in the AKI group. Since AKI 
is one of the defining criteria for severe malaria [23] 
severe malaria was also more common in the AKI group.
Identification of AKI by NGAL and KIM‑1
Five out of six patients with AKI presented with elevated 
sNGAL. uNGAL was elevated in all six (Table  2). In 
contrast, only one of the AKI patients showed elevated 
uKIM-1 at presentation. All patients that were classified 
as KDIGO stage 3, either at presentation or later during 
admission, already showed elevated concentrations of 
both sNGAL and uNGAL at presentation.
In seven patients, high concentrations of sNGAL, 
uNGAL or uKIM-1 on admission were found despite 
a seemingly normal kidney function throughout their 
admission; one had elevated sNGAL, uNGAL and uKIM-
1, two patients showed elevated sNGAL and uNGAL 
with normal uKIM-1, three patients presented with only 
an elevated uNGAL, and in one patient only uKIM-1 was 
elevated. These data are available as Additional file 4.
Diagnostic performance of sNGAL, uNGAL and uKIM‑1 
at presentation for AKI
Analysis of the diagnostic accuracy of sNGAL, uNGAL, 
uKIM-1 and the ratios of uNGAL and uKIM-1 to to urine 
creatine was performed by pair-wise comparison of the 
AUROCs of these parameters to the AUROC of serum 
creatinine. All parameters showed large AUROCs. How-
ever, none of these differences were statistically signifi-
cant when compared to the AUROC of creatinine, likely 
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due to the small sample size of this study. uNGAL was 
found to have an excellent performance with PPV of 1.00 
(95 % CI 0.54–1.00), an NPV of 1.00 (95 % CI 0.89–1.00) 
and an AUROC of 1.00 (95  % CI 1.00–1.00; Table  3). 
The ROC curves of serum creatinine, sNGAL, uNGAL, 
uKIM-1 are available as a Additional file 5.
Diagnostic performance of sNGAL, uNGAL and uKIM‑1 
at presentation for KDIGO stage 3
Analysis of the diagnostic accuracy of creatinine, NGAL 
and KIM-1 for the most severe form of AKI, KDIGO stage 
3, was also performed. uNGAL (0.99, 95  % CI 0.88–1.0) 
and sNGAL (0.97, 95 % CI 0.86–1.00) were found to per-
form excellently and all evaluated parameters had larger 
AUROCs than creatinine (AUROC of 0.75, 95 % CI 0.59–
0.87). Differences were not significant, but sample sizes in 
this sub-group were very small (see Additional file 6).
Renal replacement therapy (RRT) in relation to sNGAL, 
uNGAL and uKIM‑1 at presentation
Three patients developed a need for RRT. One of these 
patients did not classify as AKI on admission but later 
Table 1 General characteristics
Continuous variables are given as median (range). Nominal variables are given as number (percentage)
P values <0.05 are considered significant
a Self-reported use of non-steroidal anti-inflammatory drugs (NSAIDs), ACE-inhibitors, diuretics or lithium
AKI n=6 No AKI n=33 P value
Demographic findings
Age, years 43 (29–62) 46 (28–69) 0.89
Male gender 3 (50 %) 30 (91 %) <0.05
Ethnicity 1.00
Caucasian 2 (33 %) 9 (27 %) 1.00
African 4 (67 %) 22 (67 %) 1.00
Asian 0 (0 %) 2 (6 %) 1.00
Adequate prophylaxis use 0 (0 %) 0 (0 %) 1.00
Symptoms ≥8 days 2 (33 %) 6 (19 %) 0.58
Nephrotoxic co-medicationa 1 (17 %) 4 (12 %) 1.00
Clinical findings
Temperature °C 39.5 (38.3–40.1) 38.4 (35.5–40.7) 0.11
Systolic blood pressure, mmHg 100 (73–140) 125 (95–170) 0.08
Pulse rate beats/minute 111 (100–140) 95 (56–129) <0.05
Glasgow coma scale 15 (15–15) 15 (11–15) 0.54
Laboratory findings
Creatinine, µmol/L 196 (77–1081) 96 (39–133) <0.01
Urea, mmol/L 14.8 (9.1–55.8) 5.6 (2.7–33.6) <0.001
Sodium, mmol/L 129 (120–136) 137 (127–141) <0.01
Potassium, mmol/L 3.2 (2.9–3.9) 3.7 (3.3–4.5) <0.05
Lactate, mmol/L 4.5 (1.9–5.8) 1.5 (0.6–4.6) <0.001
Parasitaemia, parasites/µL 386,600 (45,900–1,380,600) 39,200 (64–678,400) <0.05
sNGAL, ng/ml 700 (174–2287) 91 (19–204) <0.001
uNGAL, ng/ml 5792 (376–22,028) 9 (1–240) <0.001
uKIM-1, ng/ml 3.9 (1.8–7.8) 1.2 (0.1–8.7) <0.01
uNGAL/ sNGAL 10.1 (0.4–25.1) 0.1 (0.0–2.6) <0.001
uNGAL/uCreatinine 815.0 (5.4–2172.7) 0.8 (0.1–42.5) <0.001
uKIM-1/uCreatinine 0.04 (0.02–0.08) 0.1 (0.0–2.9) 0.04
Concomitant bacterial infection 1 (17 %) 0 (0 %) 0.15
Outcome
Severe malaria (WHO 2014) 5 (83 %) 5 (15 %) <0.01
Renal replacement therapy 3 (50 %) 0 (0 %) <0.01
ICU admission 4 (67 %) 4 (12 %) <0.05
Death 1 (17 %) 0 (0 %) 0.15
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progressed to KDIGO stage 3, one was in KDIGO stage 
2 and one in stage 3. However, all three presented with 
elevated sNGAL and uNGAL and one also showed an 
elevated urine KIM-1 on admission.
Follow‑up measurements during admission
For two patients, sNGAL and uNGAL concentrations 
were available for follow-up during admission. One 
patient needed RRT, the other did not. Both patients 
showed elevated uNGAL at initial presentation, while 
serum creatinine concentrations were still normal. No 
major changes of sNGAL concentrations were seen dur-
ing admission (see Additional file 7).
Discussion
In the present pilot study it is demonstrated that sNGAL 
and uNGAL have an excellent predictive performance for 
malaria-induced AKI.
Biomarkers for the early detection of AKI are under 
intense investigation and studies have revealed promising 
results in a broad variety of settings including contrast-
induced nephropathy, critically ill patients, cardiac sur-
gery, and kidney transplantation [29–35]. In several 
studies, both urine and serum NGAL concentrations 
were found to be superior to the serum creatinine con-
centration for the prediction of AKI [33, 36].
Early detection of AKI in malaria could help to prevent 
further deterioration of kidney function by appropriate 
fluid management, avoidance of nephrotoxic drugs and 
close monitoring to assess the need for RRT [3, 4, 37]. 
However, very few studies on biomarkers for AKI have 
been performed in malaria. The value of uNGAL was pre-
viously studied in a cohort of adult patients with severe 
P. falciparum infection in Bangladesh. uNGAL was shown 
to increase with increasing severity of AKI [2], but creati-
nine was found to be superior to uNGAL in predicting the 
need for RRT [15]. However, patients in this study gen-
erally presented severely ill and more than half of them 
already had a decreased eGFR on admission. One could 
speculate that the benefit of an early marker for AKI can 
Table 2 KDIGO stage at initial presentation and during admission in relation to serum and urine NGAL and urine KIM-1 
for all six patients with AKI
Italics: Elevated laboratory measurements
Reference ranges in brackets
a Renal replacement therapy
KDIGO stage at  
presentation
Highest KDIGO stage  
during admission
RRTa Serum NGAL  
(≤177 ng/ml)
Urine NGAL  
(≤72 ng/ml)
Urine KIM‑1 
(≤5.33 ng/ml)
0 3 Yes 899 22,028 1.84
0 3 No 501 8691 3.88
1 2 No 174 376 4.40
2 2 No 2287 6452 3.92
2 3 Yes 205 5132 3.87
3 3 Yes 2014 838 7.75
Table 3 Descriptive statistics of  diagnostic accuracy of  various biomarker measurements at  presentation for  the pres-
ence or subsequent development of acute kidney injury (AKI)
Data are given as mean (95 % confidence interval)
Optimal cut-off values were determined using the Youden index
PPV positive predictive value; NPV negative predictive value; AUROC area under the ROC curve
* P values of pair-wise comparison of AUROCs are given (with creatinine ROC curve as comparator)
Parameter and cut‑off value Sensitivity Specificity PPV NPV Youden 
index
AUROC P value*
sCreatinine ≥ 128 µmol/L 0.83 (0.36–1.00) 0.97 (0.84–1.00) 0.83 (0.36–0.99) 0.97 (0.84–1.00) 0.80 0.85 (0.60–1.00)
sNGAL ≥ 168 ng/ml 1.00 (0.54–1.00) 0.88 (0.72–0.97) 0.60 (0.26–0.88) 1.00 (0.88–1.00) 0.88 0.98 (0.93–1.0) 0.389
uNGAL ≥ 308 ng/ml 1.00 (0.54–1.00) 1.00 (0.89–1.00) 1.00 (0.54–1.00) 1.00 (0.89–1.00) 1.00 1.00 (1.00–1.00) 0.299
uNGAL/sNGAL ≥ 1.9 0.83 (0.36–1.00) 0.97 (0.84–1.00) 0.83 (0.36–1.00) 0.96 (0.84–1.00) 0.80 0.95 (0.85–1.00) 0.544
uNGAL/uCreat ≥ 5.1 ng/mmol 1.00 (0.54–1.00) 0.88 (0.72–0.97) 0.60 (0.26–0.88) 1.00 (0.88–1.00) 0.88 0.98 (0.93–1.00) 0.390
uKIM-1 ≥ 1.83 ng/ml 1.00 (0.54–1.00) 0.72 (0.54–0.87) 0.40 (0.16–0.68) 1.00 (0.86–1.00) 0.72 0.87 (0.75–0.99) 0.919
uKIM-1 /uCreat ≤ 0.085 ng/mmol 1.00 (0.54–1.00) 0.58 (0.39–0.74) 0.30 (0.12–0.54) 1.00 (0.82–1.00) 0.58 0.76 (0.61–0.92) 0.810
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be larger in the very different population of travellers with 
imported malaria, who tend to present in a much earlier 
stage of the infection.
In the present pilot study on biomarkers of AKI 
in imported malaria, highly promising results were 
observed for uNGAL, which was able to identify all six 
AKI patients at initial presentation. Follow-up meas-
urements in two AKI patients revealed that uNGAL 
increases before serum creatinine starts to rise (Addi-
tional file  7). The AUROCs of sNGAL, uNGAL and 
uKIM-1 were large but, due to the very small sample size, 
the study was underpowered to demonstrate statistically 
significant differences. This is a major limitation of the 
present study and larger studies should be performed to 
demonstrate whether these biomarkers truly outperform 
serum creatinine.
The suggestion that uNGAL performs better than 
sNGAL, is an important discussion in literature. A meta-
analysis conducted by Haase et  al. showed that both 
serum and urine NGAL concentrations appear to per-
form similarly well and provide a relevant advantage as 
compared with serum creatinine [13]. It deserves further 
investigation whether this conclusion also applies to the 
performance of serum and urine NGAL in imported P. 
falciparum malaria. These results are important since 
oliguria is a common event in malaria-induced AKI [37] 
and the use of urine NGAL for diagnosis of malaria-
induced AKI, therefore, has its limitations. Another ongo-
ing debate is whether urine biomarker concentrations are 
better reported as absolute values or as a ratio to creati-
nine concentration [38]. In the present study, the absolute 
values seemed to perform somewhat better than the ratio.
Although uKIM-1 performed well when the cut-off 
level was set at 1.83  ng/ml, only one of the six patients 
with AKI had a uKIM-1 level above the upper limit of 
normal, which is 5.33  ng/ml, while all six patients had 
markedly raised uNGAL levels. The patient who did have 
an elevated uKIM-1 was already in KDIGO stage 3 at 
presentation. These findings raise the question whether 
the rise of KIM-1 levels occurs later in the course of early 
AKI than NGAL. A study in children undergoing cardiac 
surgery suggests that this might indeed be the case [39]. 
However, this study was performed in a study population, 
which was much different from the present, and more 
research is needed to confirm this finding in other clini-
cal settings.
Several patients were found to have elevated sNGAL, 
uNGAL or uKIM-1 but did not progress to a KDIGO 
stage 1 or higher. The clinical significance of increased 
NGAL concentrations without detectable changes in 
creatinine, previously interpreted as a shortcoming of 
the biomarker, has been found to indicate sub-clinical 
AKI and to be of prognostic importance in critically ill 
adult patients [40]. NGAL can be influenced by extra-
renal production by neutrophils caused by factors like 
concomitant systemic inflammation or malignancy [41]. 
However, it is unlikely that such bias influenced the find-
ings in the present study to a large degree as co-infection 
was ruled out and malignancy was considered unlikely in 
all patients. Follow-up of patients with elevated NGAL 
concentrations deserves further investigation, as this 
would increase insight into the correlation of NGAL and 
the resolution of AKI or the development of chronic kid-
ney disease.
An important limitation of biomarkers like NGAL 
and KIM-1 is that their availability is usually limited to 
resource-rich settings where malaria is only seen as 
an imported disease; in the regions that carry the larg-
est burden of malaria, laboratory diagnostics are often 
limited to basic measurements. Even in resource-rich 
settings, studies on the cost-effectiveness of these bio-
markers are still to be done [42].
Conclusion
This pilot study reveals good diagnostic performance 
of sNGAL, uNGAL and uKIM-1. Especially uNGAL 
was found to have an excellent predictive performance. 
Larger studies are needed to demonstrate whether these 
biomarkers are superior to serum creatinine as predictors 
for AKI in P. falciparum malaria.
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